Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
about
Gastric cancer - clinical and epidemiological aspects.Cost-effectiveness of palliative surgery versus nonsurgical procedures in gastrointestinal cancer patients.Symposium: "Oncology Leadership in Asia"Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer.Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score-matched analysis.Tspan5 is an independent favourable prognostic factor and suppresses tumour growth in gastric cancerPalliative Gastrectomy Prolongs Survival of Metastatic Gastric Cancer Patients with Normal Preoperative CEA or CA19-9 Values: A Retrospective Cohort Study.Is noncurative gastrectomy always a beneficial strategy for stage IV gastric cancer?Prognostic nutritional index is an independent prognostic factor for gastric cancer patients with peritoneal dissemination.A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis Treated with Preoperative FOLFOX Chemotherapy Followed by Radical Subtotal Gastrectomy and D2 Lymph Node Dissection.Outcomes of surgery for gastric cancer with distant metastases: a retrospective study from the SEER database.A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis from Co-Occurring Prostate CancerEffect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial.Capecitabine plus paclitaxel induction treatment in gastric cancer patients with liver metastasis: a prospective, uncontrolled, open-label Phase II clinical study.Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions.Selective survival advantage associated with primary tumor resection for metastatic gastric cancer in a Western population.Addition of peritonectomy to gastrectomy can predict good prognosis of gastric adenocarcinoma patients with intraoperatively proven single P1/P2 carcinomatosis.An update in the nonendoscopic treatment of gastric cancer.Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG.Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan.Gastric adenocarcinoma.Japanese gastric cancer treatment guidelines 2014 (ver. 4).Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England.Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis.Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging.Gastric Adenocarcinoma: A Multimodal Approach.Selective Gastric Cancer Patients with Peritoneal Seeding Benefit from Gastrectomy after Palliative Chemotherapy: A Propensity Score Matching Analysis.Prognostic factors in patients with loco-regionally advanced gastric cancer.A Case of Noncuratively Resected Gastric Cancer and Postoperative Chemotherapy with S-1 Monotherapy Resulting in Long-Term Survival for Over 8 Years.Negative lymph node count is a significant prognostic factor in patient with stage IV gastric cancer after palliative gastrectomy.The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase IHeated intraperitoneal chemotherapy and gastrectomy for gastric cancer in the U.S.: the time is now.Actionable gene-based classification toward precision medicine in gastric cancer.Staging and surgical approaches in gastric cancer: a clinical practice guideline.Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.The long-term survival of stage IV gastric cancer patients with conversion therapy.Laparoscopic Gastrojejunostomy for Patients with Unresectable Gastric Cancer with Gastric Outlet Obstruction.Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.Upregulation of ROCK2 in gastric cancer cell promotes tumor cell proliferation, metastasis and invasion.
P2860
Q30248452-70EABF20-CAF4-4689-A66F-08F26121937DQ30251459-BB8C1A18-A015-4862-AAFE-7A4329C1ACF5Q33584039-22863030-BA2D-48A7-ACF7-C113509D37AAQ36306641-8A5F70E2-E9C0-4776-AE9C-A3CA75BB76B0Q37373079-3183BC3F-5E08-4361-AF4D-480D74E68DD9Q37457827-FD0804D1-9C13-459B-97AF-AC7925BEC415Q37470903-F91A272B-11CD-4D0D-9B82-0CE3CE7E7847Q37585316-60D50232-A1B9-41FB-A037-EDD47F3B916BQ37592214-1D759929-CC51-4112-8B0D-5637249DDF04Q37695111-00C48109-A7B2-4C4D-9C7E-C79969975C93Q37706185-28A128A9-7D55-499F-BB91-49D8AE3200A0Q37717205-C48F40B7-A677-46D7-AAB7-A0AF6FDD159FQ38377462-58516568-B564-4229-ABA5-09CB3649637AQ38391749-ACF57D77-F7CB-44CC-A245-21D3D16BA5C6Q38645728-75173E2F-50F4-4B82-AB01-1FE9E7780B08Q38711200-9DCAACF6-5054-450D-9D3E-1417E8334492Q38723809-5D2DB835-9980-44D8-A248-41E6DB7E65ACQ38956298-A6C4489D-FF7B-4551-B603-B477FC945B18Q38985204-8D43D48D-4636-4636-BC49-91C07C64EAC1Q39155658-6B427961-6541-449A-81B5-386D3025C7EFQ39343374-BA4DECC5-3029-499B-8B93-B0677B7BCCF2Q39656427-116D8691-1A4D-4899-AC2C-E45A269B8C23Q39950346-78C51529-EF41-42CD-B87D-0809759EEFFBQ40055354-D9611D4F-B2BB-44B5-9CDB-5773DC60C867Q40764958-6CB4CDB8-9C34-4D65-AC45-48A5E01B4449Q41221377-E97890CD-E64F-4487-BD04-2A933FE5E0C1Q41441000-B60FD97E-AA5B-4B03-BDC5-83B2F65F8735Q41718964-DEA66E68-C132-460D-BC27-0BF8E878F96AQ42211105-8D384894-E329-49EE-8478-E50C11E46C6EQ42378523-8D05118B-ADAF-475F-B069-F9BA33E06CDFQ47096384-17EAC986-99AF-4DBA-95EB-ADEBD7971C7FQ47110681-9C0823AD-6A0E-457E-BE00-917A1E9B3135Q47113548-A4B16D6A-ECC7-465B-BF3A-FC334B966A6AQ47117808-B59CCC93-46F3-46C2-90F2-BCC815D6AD31Q47312073-75108D2A-2833-43F1-ADC3-0EADFCB377FEQ47345549-50D66BA9-2B09-4FEE-AE71-80499479DDE3Q47432838-40426094-7F3B-42A9-81CF-3F9A08C83751Q47597543-AA17A659-CCF7-4022-9695-1C2D2BE963C3Q47915753-425EF191-93B1-4AC1-9EC3-5D6FEA8699BCQ48178962-F439E8BC-88C9-4302-87BC-9E5FC9A801C0
P2860
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Gastrectomy plus chemotherapy ...... , randomised controlled trial.
@en
type
label
Gastrectomy plus chemotherapy ...... , randomised controlled trial.
@en
prefLabel
Gastrectomy plus chemotherapy ...... , randomised controlled trial.
@en
P2093
P921
P1433
P1476
Gastrectomy plus chemotherapy ...... , randomised controlled trial.
@en
P2093
Akinori Takagane
Byung Joo Park
Cho Hyun Park
Do Joong Park
Han-Kwang Yang
Junki Mizusawa
Kazumasa Fujitani
Kenichi Nakamura
Masanori Terashima
Mitsuru Sasako
P304
P356
10.1016/S1470-2045(15)00553-7
P577
2016-01-25T00:00:00Z